Sabiedrība ar ierobežotu atbildību "Pharmeko Lettland"Active

45403021522Limited liability companyFounded 2008

Key figures

9 264 074 €-23,5%
Revenue 2024
+38,8%
Average annual growth 2010–2024
05 m10 m15 m’10’11’16’17’18’19’20’21’22’23’24

Ratios

2024
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
05 m10 m15 m’10’11’16’17’18’19’20’21’22’23’24

Dividends

from the report
2024

No dividends were paid.

History
20240 €
20230 €
202220 000 €
20210 €
202025 000 €
2019120 000 €
201899 560 €
20170 €
20110 €
Summary of financial statements2010–2024
20102011201620172018201920202021202220232024
Balance sheet — assets
Total current assets167 179134 8153 764 4224 897 1555 134 7675 812 7867 438 7765 181 0896 981 0576 713 7203 586 410
Total non-current assets68 343114 8161 541 8621 768 7092 334 4892 141 9392 498 9062 266 1353 454 2045 504 3675 376 680
Total assets235 522249 6315 306 2846 665 8647 469 2567 954 7259 937 6827 447 22410 435 26112 218 0878 963 090
Balance sheet — liabilities and equity
Current liabilities53 90628 3132 592 0371 633 5831 097 0392 823 6032 477 9922 399 0774 512 9274 480 5202 762 649
Non-current liabilities108 512138 1712 140 6264 129 3135 751 7624 246 0756 454 0024 085 9414 686 4726 814 5265 720 696
Total liabilities162 418166 4844 732 6635 762 8966 848 8017 069 6788 931 9946 485 0189 199 39911 295 0468 483 345
Share capital———————————
Retained earnings of previous periods———————————
Profit for the year47 03010 043260 172589 346269 163327 316120 64116 518273 656-312 82150 509
Total equity73 10483 147573 621902 968620 455885 0471 005 688962 2061 235 862923 041479 745
Income statement
Sales revenue349 280530 7487 221 70310 168 6278 157 66011 965 25013 405 84610 954 41612 378 04212 113 1599 264 074
Operating profit53 09412 732397 534812 157362 208500 744274 965334 594652 371158 082433 709
EBITDA———1 044 442620 273892 039551 995654 412974 338558 322764 874
Profit before income tax53 09412 732301 297648 837269 163337 325120 64121 375278 039-312 82198 720
Profit for the reporting year47 03010 043260 172589 346269 163327 316120 64116 518273 656-312 82150 509
Labour costs———323 633459 906409 845465 364430 528502 727639 174535 675
Depreciation of non-current assets———232 285258 065391 295277 030319 818321 967400 240331 165
Other indicators
Employees1623424753442825263126
Calculated dividend—0—099 560120 00025 000020 00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

50%35%15%65%Sabiedrība ar ierobež…Stolk Medicinal Plant…SIA SEPHAIL Sentiero S.A.S. Di…4Monesi AlessandroStolk Pieter Cornelis…
CompanyPersonShareholderOther roleAdditional link

Related companies

Same registered address

Summary: Sabiedrība ar ierobežotu atbildību "Pharmeko Lettland"

Overview

Sabiedrība ar ierobežotu atbildību "Pharmeko Lettland" (reg. no. 45403021522) is a limited liability company. The company was registered in 2008 and has been in the register for 18 years. Registered address: Madonas nov., Madona, Saules iela 65A.

Financial results

Revenue in 2024 was 9 264 074 €, down 23,5% on the previous year (12 113 159 €). From 2010 to 2024, revenue grew by an average of 38,8% per year. Net profit for 2024 was 50 509 € (0,5% of revenue). The company was profitable in 10 of the 11 published years. In 2024 the company had 26 employees (31 a year earlier). Revenue per employee was 356 311 €. At the end of 2024, total assets were 8 963 090 € and equity 479 745 € (5,4% of assets).

Management and owners

The board has 2 members. According to the register, the company has 3 owners. The largest stake (50%) is held by Stolk Medicinal Plants B.V..

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.